HCPCS Level II
J2700
Injection, oxacillin sodium, up to 250 mg
Codes near J2700
These sit next to J2700 in the CMS Level II file. All J codes
- J2670Injection, tolazoline hcl, up to 25 mg
- J2675Injection, progesterone, per 50 mg
- J2679Injection, fluphenazine hcl, 1.25 mg
- J2680Injection, fluphenazine decanoate, up to 25 mg
- J2690Injection, procainamide hcl, up to 1 gm
- J2704Injection, propofol, 10 mg
- J2710Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720Injection, protamine sulfate, per 10 mg
- J2724Injection, protein c concentrate, intravenous, human, 10 iu
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00338-1015-41 | Bactocill In Dextrose | Baxter Healthcare Corporation | 8 |
| 25021-0146-10 | Oxacillin Sodium | Sagent Pharmaceuticals | 40 |
| 25021-0162-24 | Oxacillin Sodium | Sagent Pharmaceuticals | 80 |
| 25021-0162-68 | Oxacillin Sodium | Sagent Pharmaceuticals | 80 |
| 25021-0163-68 | Oxacillin Sodium | Sagent Pharmaceuticals | 400 |
| 25021-0163-97 | Oxacillin Sodium | Sagent Pharmaceuticals | 40 |
| 25021-0163-99 | Oxacillin Sodium | Sagent Pharmaceuticals | 400 |
| 55150-0127-15 | Oxacillin Sodium | Eugia US LLC | 40 |
| 55150-0128-24 | Oxacillin Sodium | Eugia US LLC | 80 |
| 55150-0129-99 | Oxacillin Sodium | Eugia US LLC | 40 |
| 63323-0811-00 | Oxacillin Sodium | FreseniUS Kabi USA, LLC | 40 |
| 63323-0812-20 | Oxacillin Sodium | FreseniUS Kabi USA, LLC | 80 |
| 63323-0813-20 | Oxacillin Sodium | FreseniUS Kabi USA, LLC | 40 |
| 72485-0409-10 | Oxacillin Sodium | Armas Pharmaceuticals Inc. | 80 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.